These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 25047227

  • 1. Body composition and weight gain in new users of the three-monthly injectable contraceptive, depot-medroxyprogesterone acetate, after 12 months of follow-up.
    dos Santos Pde N, Modesto WO, Dal'Ava N, Bahamondes MV, Pavin EJ, Fernandes A.
    Eur J Contracept Reprod Health Care; 2014 Dec; 19(6):432-8. PubMed ID: 25047227
    [Abstract] [Full Text] [Related]

  • 2. Body weight and body composition of depot medroxyprogesterone acetate users.
    Dal'Ava N, Bahamondes L, Bahamondes MV, Bottura BF, Monteiro I.
    Contraception; 2014 Aug; 90(2):182-7. PubMed ID: 24780631
    [Abstract] [Full Text] [Related]

  • 3. Insulin resistance parameters in users of the injectable contraceptive depot medroxyprogesterone acetate during one year of use.
    Cursino K, Sider M, Pavin EJ, dos Santos Pde N, Bahamondes L, Zantut-Wittmann DE, Fernandes A.
    Eur J Contracept Reprod Health Care; 2016 Aug; 21(1):22-9. PubMed ID: 26140543
    [Abstract] [Full Text] [Related]

  • 4. Body weight and composition in users of levonorgestrel-releasing intrauterine system.
    Dal'Ava N, Bahamondes L, Bahamondes MV, de Oliveira Santos A, Monteiro I.
    Contraception; 2012 Oct; 86(4):350-3. PubMed ID: 22445431
    [Abstract] [Full Text] [Related]

  • 5. A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.
    Viola AS, Castro S, Bahamondes MV, Fernandes A, Viola CF, Bahamondes L.
    Contraception; 2011 Nov; 84(5):e31-7. PubMed ID: 22018135
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Variations in body mass index of users of depot-medroxyprogesterone acetate as a contraceptive.
    Pantoja M, Medeiros T, Baccarin MC, Morais SS, Bahamondes L, Fernandes AM.
    Contraception; 2010 Feb; 81(2):107-11. PubMed ID: 20103446
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human vaginal histology in long-term users of the injectable contraceptive depot-medroxyprogesterone acetate.
    Bahamondes MV, Castro S, Marchi NM, Marcovici M, Andrade LA, Fernandes A, Bahamondes L.
    Contraception; 2014 Aug; 90(2):117-22. PubMed ID: 24613369
    [Abstract] [Full Text] [Related]

  • 11. Weight and body fat changes in postpartum depot-medroxyprogesterone acetate users.
    Nyirati CM, Habash DL, Shaffer LE.
    Contraception; 2013 Jul; 88(1):169-76. PubMed ID: 23177262
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Weight variation in users of depot-medroxyprogesterone acetate, the levonorgestrel-releasing intrauterine system and a copper intrauterine device for up to ten years of use.
    Modesto W, de Nazaré Silva dos Santos P, Correia VM, Borges L, Bahamondes L.
    Eur J Contracept Reprod Health Care; 2015 Feb; 20(1):57-63. PubMed ID: 25160484
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bone mineral density in long-term depot medroxyprogesterone acetate acceptors.
    Taneepanichskul S, Intaraprasert S, Theppisai U, Chaturachinda K.
    Contraception; 1997 Jul; 56(1):1-3. PubMed ID: 9306024
    [Abstract] [Full Text] [Related]

  • 16. Weight change at 12 months in users of three progestin-only contraceptive methods.
    Vickery Z, Madden T, Zhao Q, Secura GM, Allsworth JE, Peipert JF.
    Contraception; 2013 Oct; 88(4):503-8. PubMed ID: 23582238
    [Abstract] [Full Text] [Related]

  • 17. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
    Polaneczky M, Guarnaccia M, Alon J, Wiley J.
    Fam Plann Perspect; 1996 Oct; 28(4):174-8. PubMed ID: 8853283
    [Abstract] [Full Text] [Related]

  • 18. A pilot study examining short-term changes in bone mineral density among class 3 obese users of depot-medroxyprogesterone acetate.
    Segall-Gutierrez P, Agarwal R, Ge M, Lopez C, Hernandez G, Stanczyk FZ.
    Eur J Contracept Reprod Health Care; 2013 Jun; 18(3):199-205. PubMed ID: 23530919
    [Abstract] [Full Text] [Related]

  • 19. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.
    Clark MK, Sowers MR, Nichols S, Levy B.
    Fertil Steril; 2004 Dec; 82(6):1580-6. PubMed ID: 15589863
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of Low Bone Mass and Osteoporosis in Long-Term Users of the Injectable Contraceptive Depot Medroxyprogesterone Acetate.
    Modesto W, Bahamondes MV, Bahamondes L.
    J Womens Health (Larchmt); 2015 Aug; 24(8):636-40. PubMed ID: 26098552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.